After we have established that MYPT1 overexpression can inhibit the metastasis of ccRCC, we examined the expression of major EMT effectors, including E‐cadherin, N‐cadherin and Vimentin. The gene discussed is CDH1; the disease is nonpapillary renal cell carcinoma.